Tyr406
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr406  -  GAB1 (human)

Site Information
DAssQDCyDIPRAFP   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 447946
Available spectra:  2 CST
Associated spectra:  2 CST

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 220 ) , mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 , 523 , 524 , 525 , 526 , 527 , 528 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 591 , 592 , 593 , 594 , 596 , 597 , 598 , 599 , 600 , 601 , 602 , 603 , 604 , 605 , 606 , 607 , 608 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 619 , 620 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 , 630 , 631 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 744 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 , 821 , 822 , 823 , 824 , 825 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 837 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 903 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 912 , 913 , 914 , 915 , 916 , 917 , 918 , 919 , 920 , 921 , 922 , 923 , 924 , 925 , 926 , 927 , 928 , 929 , 930 , 931 , 932 , 933 , 934 , 935 , 936 , 937 , 938 , 939 , 940 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1015 , 1016 , 1017 , 1018 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1034 , 1035 , 1036 , 1037 , 1038 , 1039 , 1040 , 1041 , 1042 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1051 , 1052 , 1053 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1061 , 1062 , 1063 , 1064 , 1065 , 1066 , 1067 , 1068 , 1069 , 1070 , 1071 , 1072 , 1074 ) , mutation of modification site ( 220 ) , phospho-antibody ( 220 ) , western blotting ( 220 )
Disease tissue studied:
atrial fibrillation ( 549 ) , adenoid cystic carcinoma ( 483 , 485 ) , bile-duct cancer ( 45 , 46 , 47 , 453 , 456 , 457 , 458 , 475 , 506 ) , bladder cancer ( 722 , 723 , 725 , 726 , 775 , 813 ) , bone cancer ( 19 , 596 , 611 , 612 , 613 , 1045 ) , Ewing's sarcoma ( 19 , 611 ) , osteosarcoma ( 19 , 596 , 612 , 613 , 1045 ) , brain cancer ( 3 , 17 , 89 , 90 , 101 , 511 , 512 , 521 , 522 , 523 , 576 , 577 , 578 , 626 , 628 , 629 , 735 , 806 , 847 , 905 , 906 , 916 , 924 , 927 , 928 , 929 , 930 , 931 , 933 , 934 , 940 , 945 , 946 , 947 , 972 , 974 , 983 , 1017 , 1029 ) , astrocytoma ( 89 , 90 , 101 , 806 , 933 , 940 , 1029 ) , glioblastoma ( 3 , 735 , 847 , 905 , 906 , 916 , 927 , 929 , 930 , 931 , 945 , 946 , 947 , 972 , 974 , 983 , 1017 ) , glioblastoma multiforme ( 17 , 511 , 512 , 521 , 522 , 523 , 576 , 577 , 578 , 626 , 628 , 629 , 847 , 916 , 927 , 946 , 972 , 974 ) , glioma ( 3 , 17 , 511 , 512 , 521 , 522 , 523 , 576 , 577 , 578 , 626 , 628 , 629 , 735 , 847 , 905 , 906 , 916 , 927 , 929 , 930 , 931 , 945 , 946 , 947 , 972 , 974 , 983 , 1017 ) , breast cancer ( 6 , 318 , 319 , 320 , 357 , 358 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 544 , 545 , 546 , 547 , 548 , 550 , 551 , 560 , 588 , 618 , 619 , 620 , 630 , 631 , 634 , 635 , 717 , 718 , 719 , 743 , 744 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 771 , 772 , 776 , 777 , 778 , 790 , 814 , 817 , 818 , 828 , 829 , 834 , 837 , 944 , 961 , 964 , 965 , 975 , 1011 , 1014 , 1015 , 1016 , 1067 , 1068 ) , breast adenocarcinoma ( 771 , 790 , 834 , 964 , 1011 , 1016 , 1067 , 1068 ) , breast ductal carcinoma ( 944 , 965 ) , luminal A breast cancer ( 1 ) , luminal B breast cancer ( 1 ) , breast cancer, surrounding tissue ( 318 , 319 , 320 ) , breast cancer, triple negative ( 6 , 747 , 748 , 749 , 750 , 961 , 965 , 975 ) , colorectal cancer ( 19 , 48 , 49 , 50 , 78 , 85 , 86 , 97 , 98 , 136 , 671 , 786 , 848 , 849 , 856 , 885 , 968 , 997 , 1002 , 1026 , 1027 , 1031 , 1032 , 1053 , 1054 , 1055 ) , colorectal carcinoma ( 19 , 48 , 49 , 50 , 85 , 86 , 97 , 98 , 671 , 786 , 848 , 849 , 885 , 968 , 997 , 1002 , 1026 , 1027 , 1031 , 1032 , 1053 , 1054 , 1055 ) , colorectal cancer, surrounding tissue ( 137 , 138 , 411 , 415 , 431 ) , esophageal cancer ( 44 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 348 , 376 , 384 , 391 , 394 , 400 , 401 , 403 , 760 , 761 , 762 , 763 , 796 , 797 , 798 , 799 , 815 , 816 , 902 , 903 , 904 , 908 , 909 , 910 , 917 , 918 ) , esophageal carcinoma ( 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 760 , 761 , 762 , 763 , 799 , 815 , 908 , 909 , 910 , 917 , 918 ) , esophageal cancer, surrounding tissue ( 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 385 , 386 , 387 , 388 , 389 , 390 , 392 , 393 , 395 , 396 , 397 , 398 , 399 , 402 , 404 , 405 ) , gallbladder cancer ( 509 ) , gallbladder carcinoma ( 509 ) , gastric cancer ( 20 , 21 , 22 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 87 , 88 , 99 , 100 , 156 , 157 , 178 , 179 , 180 , 181 , 183 , 184 , 221 , 223 , 228 , 297 , 299 , 300 , 301 , 302 , 303 , 307 , 308 , 412 , 413 , 414 , 493 , 494 , 495 , 498 , 499 , 501 , 554 , 556 , 564 , 568 , 571 , 572 , 573 , 574 , 575 , 580 , 582 , 583 , 584 , 585 , 586 , 592 , 632 , 633 , 663 , 664 , 669 , 670 , 758 , 844 , 845 , 846 , 850 , 854 ) , gastric carcinoma ( 20 , 21 , 22 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 87 , 88 , 99 , 100 , 156 , 157 , 178 , 179 , 180 , 181 , 183 , 184 , 221 , 223 , 228 , 412 , 413 , 414 , 493 , 494 , 495 , 498 , 554 , 556 , 564 , 568 , 592 , 632 , 663 , 664 , 669 , 670 , 845 ) , gastric carcinoma, surrounding tissue ( 298 , 304 , 305 , 306 , 309 , 496 , 497 , 500 , 502 , 503 , 553 , 555 , 561 , 562 , 563 ) , kidney cancer ( 721 , 773 ) , leukemia ( 51 , 52 , 53 , 54 , 55 , 56 , 57 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 182 , 185 , 196 , 198 , 199 , 201 , 202 , 206 , 207 , 208 , 210 , 212 , 213 , 214 , 215 , 222 , 224 , 229 , 230 , 231 , 232 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 321 , 322 , 323 , 324 , 332 , 333 , 334 , 337 , 338 , 339 , 340 , 341 , 342 , 354 , 356 , 436 , 437 , 438 , 439 , 440 , 444 , 445 , 446 , 447 , 448 , 449 , 528 , 529 , 538 , 539 , 540 , 541 , 542 , 543 , 552 , 557 , 558 , 566 , 579 , 581 , 587 , 605 , 606 , 607 , 608 , 609 , 610 , 614 , 615 , 616 , 617 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 652 , 665 , 666 , 667 , 668 , 672 , 673 , 675 , 676 , 677 , 679 , 739 , 740 , 741 , 742 , 769 , 770 , 785 , 787 , 801 , 802 , 803 , 809 , 810 , 811 , 812 , 839 , 840 , 841 , 842 , 851 , 855 , 859 , 860 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 886 , 887 , 888 , 889 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 923 , 926 , 949 , 950 , 951 , 952 , 953 , 954 , 979 , 986 , 995 , 996 , 1003 , 1004 , 1023 , 1028 , 1035 , 1042 , 1043 , 1049 , 1050 , 1057 , 1061 , 1062 , 1069 , 1070 , 1071 , 1072 ) , acute lymphocytic leukemia ( 135 , 769 , 770 , 785 , 787 , 855 , 859 , 901 , 1035 , 1049 , 1057 ) , acute myelogenous leukemia ( 652 , 801 , 802 , 803 , 860 , 899 , 900 , 926 , 979 , 995 , 996 , 1003 , 1004 , 1023 ) , chronic myelogenous leukemia ( 51 , 52 , 53 , 54 , 55 , 56 , 57 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 182 , 185 , 196 , 198 , 199 , 201 , 202 , 206 , 207 , 208 , 210 , 212 , 213 , 214 , 215 , 222 , 224 , 229 , 230 , 231 , 232 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 321 , 322 , 323 , 324 , 332 , 333 , 334 , 337 , 338 , 339 , 340 , 341 , 342 , 354 , 356 , 436 , 437 , 438 , 439 , 440 , 444 , 445 , 446 , 447 , 448 , 449 , 528 , 529 , 538 , 539 , 540 , 541 , 542 , 543 , 552 , 557 , 558 , 566 , 579 , 581 , 587 , 605 , 606 , 607 , 608 , 609 , 610 , 614 , 615 , 616 , 617 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 665 , 666 , 667 , 668 , 672 , 673 , 675 , 676 , 677 , 679 , 739 , 740 , 741 , 742 , 809 , 810 , 811 , 812 , 839 , 840 , 841 , 842 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 886 , 887 , 888 , 889 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 923 , 949 , 950 , 951 , 952 , 953 , 954 , 986 , 1028 , 1042 , 1043 , 1050 , 1061 , 1062 , 1069 , 1070 , 1071 , 1072 ) , liver cancer ( 328 , 329 , 335 , 336 , 409 , 410 , 418 , 419 , 420 , 421 , 452 , 455 , 472 , 473 , 474 , 476 , 508 , 510 ) , liver adenocarcinoma ( 410 ) , cholangiocellular carcinoma ( 508 ) , cholangiocellular carcinoma, surrounding tissue ( 430 ) , hepatocellular carcinoma ( 328 , 329 , 335 , 336 , 420 , 421 ) , hepatocellular carcinoma, surrounding tissue ( 325 , 326 , 327 , 331 , 416 , 417 ) , lung cancer ( 5 , 7 , 8 , 9 , 10 , 11 , 12 , 15 , 18 , 23 , 24 , 25 , 26 , 79 , 80 , 81 , 82 , 83 , 84 , 91 , 92 , 93 , 94 , 95 , 96 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 111 , 118 , 163 , 164 , 186 , 197 , 203 , 205 , 219 , 228 , 279 , 343 , 344 , 345 , 346 , 347 , 349 , 350 , 351 , 422 , 423 , 432 , 433 , 434 , 435 , 441 , 442 , 443 , 469 , 470 , 471 , 504 , 505 , 565 , 592 , 593 , 594 , 621 , 622 , 636 , 637 , 638 , 639 , 658 , 659 , 660 , 661 , 662 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 724 , 727 , 730 , 759 , 779 , 780 , 781 , 782 , 783 , 784 , 800 , 804 , 805 , 820 , 821 , 825 , 827 , 830 , 831 , 832 , 833 , 835 , 836 , 838 , 843 , 876 , 913 , 914 , 915 , 919 , 920 , 921 , 925 , 932 , 935 , 936 , 937 , 938 , 939 , 942 , 943 , 948 , 966 , 969 , 970 , 976 , 980 , 981 , 982 , 984 , 985 , 987 , 988 , 989 , 990 , 991 , 1000 , 1001 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1018 , 1020 , 1022 , 1024 , 1025 , 1030 , 1037 , 1038 , 1040 , 1041 , 1044 , 1046 , 1047 , 1048 , 1056 , 1058 , 1059 ) , non-small cell lung cancer ( 5 , 7 , 8 , 10 , 11 , 12 , 13 , 14 , 18 , 23 , 24 , 25 , 26 , 79 , 80 , 81 , 82 , 83 , 84 , 91 , 92 , 93 , 94 , 95 , 96 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 111 , 163 , 164 , 219 , 279 , 350 , 422 , 423 , 432 , 433 , 434 , 469 , 470 , 471 , 504 , 565 , 592 , 593 , 594 , 621 , 622 , 637 , 638 , 639 , 658 , 659 , 660 , 661 , 662 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 700 , 701 , 702 , 703 , 711 , 712 , 713 , 714 , 715 , 716 , 759 , 779 , 780 , 781 , 782 , 783 , 784 , 800 , 804 , 805 , 827 , 830 , 831 , 832 , 833 , 835 , 836 , 838 , 843 , 876 , 913 , 914 , 915 , 919 , 920 , 921 , 925 , 935 , 936 , 937 , 938 , 939 , 943 , 948 , 966 , 969 , 970 , 976 , 980 , 981 , 982 , 984 , 985 , 987 , 988 , 989 , 991 , 1000 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1018 , 1020 , 1022 , 1024 , 1025 , 1030 , 1037 , 1038 , 1040 , 1041 , 1046 , 1047 , 1056 , 1058 , 1059 ) , non-small cell lung cancer, surrounding tissue ( 217 , 218 , 406 , 515 ) , non-small cell lung adenocarcinoma ( 5 , 7 , 8 , 9 , 10 , 11 , 12 , 14 , 15 , 81 , 82 , 83 , 84 , 93 , 94 , 95 , 96 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 111 , 163 , 164 , 186 , 228 , 279 , 432 , 433 , 434 , 471 , 504 , 592 , 637 , 638 , 639 , 660 , 661 , 662 , 727 , 730 , 825 , 989 , 1000 , 1008 , 1037 , 1041 ) , non-small cell lung adenocarcinoma, surrounding tissue ( 110 , 273 , 274 , 275 , 276 , 277 , 278 , 280 , 281 , 282 ) , non-small cell large cell lung carcinoma ( 10 , 724 ) , non-small cell squamous cell lung carcinoma ( 9 , 343 , 344 , 345 , 346 , 347 , 349 , 351 , 435 , 441 , 442 , 443 , 505 , 976 ) , small-cell lung cancer ( 942 , 1048 ) , lung cancer, surrounding tissue ( 116 , 117 , 148 , 200 , 204 , 209 , 211 , 477 ) , lymphoma ( 112 , 570 , 755 , 756 , 852 , 922 ) , B cell lymphoma ( 112 , 922 ) , Hodgkin's lymphoma ( 755 , 756 , 852 ) , neuroblastoma ( 2 , 16 , 144 , 145 , 146 , 147 , 160 , 161 , 466 , 467 , 468 , 567 , 736 , 737 , 738 , 765 , 807 , 808 , 853 , 924 , 928 , 934 ) , ovarian cancer ( 120 , 139 , 140 , 141 , 142 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 158 , 159 , 225 , 226 , 227 , 599 , 600 , 602 , 603 , 861 , 862 , 863 , 864 , 865 , 866 , 967 ) , ovarian epithelial carcinoma ( 120 , 140 , 158 , 159 ) , pancreatic cancer ( 1051 , 1052 , 1064 , 1065 , 1066 ) , pancreatic carcinoma ( 1066 ) , pancreatic cancer, surrounding tissue ( 355 , 559 ) , multiple myeloma ( 407 , 408 , 822 , 823 , 824 , 912 , 992 , 993 , 994 ) , prostate cancer ( 1060 ) , salivary gland cancer ( 461 , 462 , 463 , 464 , 465 ) , melanoma skin cancer ( 260 , 450 , 451 , 454 , 507 ) , leiomyosarcoma ( 19 ) , rhabdomyosarcoma ( 19 ) , teratoma ( 216 ) , teratoma, surrounding tissue ( 524 ) , thymic carcinoma ( 113 , 114 ) , ventricular tachycardia ( 115 , 121 , 122 , 123 ) , hypersplenism ( 569 )
Relevant cell line - cell type - tissue:
'liver, para-cholangiocellular carcinoma tissue' ( 133 ) , 143.98.2 (bone cell) ( 613 ) , 184A1 (epithelial) [HER2 (human), transfection] ( 764 ) , 184A1 (epithelial) ( 330 , 764 ) , 23132/87 (gastric) ( 845 ) , 293 (epithelial) [EFNB1 (human), transfection] ( 233 ) , 293 (epithelial) [EphB2 (human), transfection] ( 233 ) , 293 (epithelial) ( 220 ) , 44-ZW-5409 (eye cell) ( 629 ) , 47-CD-3188 (glial) ( 626 ) , 56-DT-9110 (glial) ( 628 ) , 5637 (bladder cell) ( 775 ) , 639V (renal) ( 721 ) , 8-MG-BA (glial) ( 927 ) , A172 (glial) ( 905 , 906 , 1017 ) , A204 (muscle cell) ( 19 ) , A498 (renal) ( 794 ) , A549 (pulmonary) ( 7 , 15 , 636 ) , A673 (muscle cell) ( 19 ) , ACC-S (adenoidal) ( 482 , 484 ) , AGS (gastric) ( 850 ) , AU565 (breast cell) ( 743 , 744 ) , AZ-521 (gastric) ( 573 ) , BC-3C (bladder cell) ( 722 ) , BEAS-2B (epithelial) [LKB1 (human), no information] ( 426 , 427 ) , BEAS-2B (epithelial) ( 424 , 425 ) , bone marrow ( 652 ) , brain ( 847 ) , breast ( 1 , 6 , 318 , 319 , 320 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 544 , 545 , 546 , 547 , 548 , 550 , 551 , 560 , 588 , 618 , 619 , 620 , 776 , 777 , 778 ) , BT-20 (breast cell) ( 634 , 635 ) , BT-474 (breast cell) ( 357 ) , BV-173 (myeloid) ( 877 , 1028 , 1050 ) , BxPC-3 (pancreatic) ( 1051 , 1052 , 1064 , 1065 ) , Caki-2 (renal) ( 774 , 792 , 795 ) , Cal-12T (pulmonary) ( 12 , 948 ) , CAL-148 (breast cell) ( 814 ) , CAL-29 (bladder cell) ( 726 ) , CAL-51 (breast cell) ( 745 , 746 ) , CAL-85-1 (breast cell) ( 771 , 834 ) , Calu-3 (pulmonary) ( 8 , 990 , 1044 ) , Caov-3 (ovarian) ( 866 ) , cardiac-heart ( 121 ) , CAS-1 (glial) ( 735 ) , CHP126 (neural crest) ( 2 , 765 ) , CHP212 (neural crest) ( 2 , 924 ) , CHRF (megakaryocyte) ( 801 , 996 ) , COLO-680N (esophageal) [RAIG1 (human), knockdown] ( 44 ) , COLO-680N (esophageal) ( 195 , 816 ) , COLO-699 (pulmonary) ( 832 ) , COLO-704 (ovarian) ( 865 ) , COLO-824 (breast cell) ( 790 ) , colon ( 136 , 137 , 138 , 411 , 415 , 431 ) , DBTRG-05MG (glial) ( 972 ) , DK-MG (glial) ( 916 ) , DLD1 (intestinal) ( 19 , 78 ) , DMS153 (pulmonary) ( 11 , 941 , 1048 ) , DV-90 (pulmonary) ( 821 ) , EFM-19 (breast cell) ( 791 ) , EFM-192A (breast cell) ( 817 ) , EFO-21 (ovarian) ( 861 ) , EFO-27 (ovarian) ( 862 ) , EGI-1 (bile-duct cell) ( 506 ) , esophagus ( 348 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 ) , EVSA-T (breast cell) ( 828 ) , GAMG (glial) ( 930 ) , GDM-1 (myeloid) ( 1004 ) , germ cell-teratoma ( 524 ) , GI-CA-N (neural crest) ( 2 , 736 ) , glial-brain ( 3 , 17 ) , H2009 (pulmonary) ( 18 ) , H2887 (pulmonary) ( 18 ) , HCC1143 (breast cell) ( 965 ) , HCC1395 (breast cell) ( 944 ) , HCC1428 (breast cell) ( 964 ) , HCC15 (pulmonary) ( 9 ) , HCC1599 (breast cell) ( 717 , 718 ) , HCC1806 (breast cell) ( 975 ) , HCC1937 (breast cell) ( 961 ) , HCC202 (breast cell) ( 630 , 631 ) , HCC366 (pulmonary) ( 18 , 1022 ) , HCC38 (breast cell) ( 747 , 748 ) , HCC44 (pulmonary) ( 12 , 1010 ) , HCC70 (breast cell) ( 749 , 750 ) , HCC78 (pulmonary) ( 10 , 18 , 83 , 84 , 95 , 96 , 471 , 781 , 782 , 936 , 1009 ) , HCC827 (pulmonary) ( 8 , 18 , 163 , 164 , 186 , 592 , 637 , 638 , 639 , 660 , 661 , 662 , 989 , 1037 , 1041 ) , HCT116 (intestinal) ( 48 , 49 , 50 , 85 , 86 , 97 , 98 , 671 , 786 , 1031 , 1032 ) , HCT8 (intestinal) ( 885 ) , HD-MyZ (myeloid) ( 756 , 852 ) , HDQ-P1 (breast cell) ( 818 ) , heart ( 115 , 122 , 123 , 549 ) , HEL (erythroid) ( 802 , 803 , 979 ) , HeLa (cervical) ( 4 , 459 , 460 , 514 , 518 , 519 , 520 ) , Hep 3B2.1-7 (hepatic) ( 473 ) , hepatic-'liver, para-cholangiocellular carcinoma tissue' ( 430 ) , hepatic-'liver, para-hepatocellular carcinoma tissue' ( 325 , 326 , 327 , 331 , 416 , 417 ) , hepatocyte-liver ( 328 , 329 ) , HepG2 (hepatic) ( 336 ) , HES-3 ('stem, embryonic') ( 134 ) , HLE (hepatic) ( 420 ) , HLF (hepatic) ( 335 ) , HMEC (endothelial) ( 640 ) , HOP62 (pulmonary) ( 18 ) , HPAC (pancreatic) ( 1066 ) , HT-29 (intestinal) ( 848 , 849 , 1002 , 1026 , 1027 , 1036 , 1053 , 1054 , 1055 ) , HuCCT1 (hepatic) ( 508 ) , Huh1 (hepatic) ( 421 ) , Huh6 (hepatic) ( 510 ) , HUVEC (endothelial) ( 486 , 487 , 488 , 489 , 490 , 491 , 492 ) , IM95 (gastric) ( 574 ) , J82 (bladder cell) ( 793 ) , JEKO-1 (B lymphocyte) ( 112 , 570 ) , JHH-2 (hepatic) ( 476 ) , JHH-4 (hepatic) ( 452 ) , JHH-5 (hepatic) ( 474 ) , JHH-7 (hepatic) ( 472 ) , JIMT-1 (breast cell) ( 772 , 829 ) , Jurkat (T lymphocyte) ( 119 , 525 , 911 ) , K562 (erythroid) ( 51 , 52 , 53 , 54 , 55 , 56 , 57 , 77 , 102 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 182 , 185 , 196 , 198 , 199 , 201 , 202 , 206 , 207 , 208 , 210 , 212 , 213 , 214 , 215 , 222 , 224 , 229 , 230 , 231 , 232 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 321 , 322 , 323 , 324 , 332 , 333 , 334 , 337 , 338 , 339 , 340 , 341 , 342 , 352 , 353 , 354 , 356 , 436 , 437 , 438 , 439 , 440 , 444 , 445 , 446 , 447 , 448 , 449 , 513 , 526 , 528 , 529 , 538 , 539 , 540 , 541 , 542 , 543 , 552 , 557 , 558 , 566 , 579 , 581 , 587 , 589 , 590 , 591 , 597 , 598 , 605 , 606 , 607 , 608 , 609 , 610 , 614 , 615 , 616 , 617 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 653 , 654 , 655 , 656 , 657 , 665 , 666 , 667 , 668 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 739 , 740 , 741 , 742 , 754 , 757 , 788 , 789 , 809 , 810 , 811 , 812 , 839 , 840 , 841 , 842 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 923 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 973 , 986 , 1042 , 1043 , 1061 , 1062 , 1069 , 1070 , 1071 , 1072 ) , KATO III (gastric) ( 846 ) , KELLY (neural crest) ( 2 , 853 ) , KMS-11 (B lymphocyte) ( 250 ) , KMS-18 (B lymphocyte) ( 993 ) , KPL-1 (breast cell) ( 837 ) , Kyse140 (esophageal) ( 193 , 760 , 761 , 762 , 763 , 909 , 917 ) , Kyse150 (esophageal) ( 188 , 799 ) , Kyse180 (esophageal) ( 194 , 910 , 918 ) , Kyse270 (esophageal) ( 191 , 796 , 797 , 798 , 902 ) , Kyse30 (esophageal) ( 187 , 908 ) , Kyse410 (esophageal) ( 192 ) , Kyse450 (squamous) ( 904 ) , Kyse510 (esophageal) ( 190 , 903 ) , Kyse520 (esophageal) ( 189 ) , Kyse70 (esophageal) ( 815 ) , L428 (lymphoid) ( 755 ) , LAN-1 (neural crest) ( 2 , 737 ) , LAN-5 (neural crest) ( 2 , 738 ) , LAN-6 (neural crest) ( 2 , 146 , 466 , 467 , 468 ) , LCLC-103H (pulmonary) ( 18 , 830 ) , liver ( 418 ) , LN18 (glial) ( 511 , 512 , 521 , 522 , 523 , 576 , 577 , 578 , 946 ) , LN229 (glial) ( 947 ) , LN405 (glial) ( 806 ) , LNCaP (prostate cell) ( 1060 ) , LOU-NH91 (squamous) ( 9 ) , lung ( 7 , 8 , 9 , 10 , 11 , 12 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 116 , 117 , 118 , 148 , 197 , 200 , 203 , 204 , 205 , 209 , 211 , 217 , 218 , 219 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 343 , 344 , 345 , 346 , 347 , 349 , 350 , 351 , 406 , 432 , 433 , 434 , 435 , 441 , 442 , 443 , 477 , 504 , 505 , 515 , 565 , 593 , 594 , 621 , 622 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 779 , 783 , 784 , 800 , 804 , 805 , 843 , 857 , 858 , 919 , 920 , 921 , 925 , 932 , 962 , 963 , 970 , 971 , 977 , 978 , 998 , 999 , 1012 , 1013 , 1019 , 1020 , 1021 , 1025 , 1033 ) , LXF-289 (pulmonary) ( 831 ) , M059J (glial) ( 945 ) , M059K (glial) ( 983 ) , MCF-10A (breast cell) [CSFR (human), transfection] ( 143 ) , MCF-10A (breast cell) ( 1014 , 1015 ) , MCF-7 (breast cell) ( 1067 ) , MDA-MB-361 (breast cell) ( 358 ) , MDA-MB-453 (breast cell) ( 1016 ) , MDA-MB-468 (breast cell) ( 1068 ) , MDAH2774 (ovarian) ( 863 ) , MG63 (bone cell) ( 596 ) , MHH-CALL4 (B lymphocyte) ( 855 , 859 ) , MKN-45 (gastric) ( 20 , 21 , 22 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 87 , 88 , 99 , 100 , 156 , 157 , 178 , 179 , 180 , 181 , 183 , 184 , 221 , 223 , 228 , 412 , 413 , 414 , 480 , 481 , 592 , 632 , 633 , 663 , 664 , 669 , 670 , 854 ) , MKN-7 (gastric) ( 584 ) , MKN-74 (gastric) ( 585 ) , MKPL-1 (megakaryoblast) ( 625 , 860 , 1023 ) , MNNG-HOS (bone cell) ( 19 , 1045 ) , MO-91 (myeloid) ( 926 ) , MUTZ-5 (B lymphocyte) ( 769 , 770 ) , MV4-11 (macrophage) ( 899 , 995 ) , N87 (gastric) ( 1034 ) , NALM19 (B lymphocyte) ( 851 ) , NB10 (neural crest) ( 16 ) , NCCIT (epithelial) ( 216 ) , NCI-H1355 (pulmonary) ( 7 , 820 ) , NCI-H1373 (pulmonary) ( 1056 ) , NCI-H1395 (pulmonary) ( 18 ) , NCI-H1435 (pulmonary) ( 966 ) , NCI-H1437 (pulmonary) ( 11 , 12 , 1006 ) , NCI-H1563 (pulmonary) ( 969 ) , NCI-H1568 (pulmonary) ( 1005 ) , NCI-H1648 (pulmonary) ( 982 ) , NCI-H1650 (pulmonary) ( 8 , 23 , 24 , 25 , 26 , 79 , 80 , 91 , 92 , 592 , 980 , 981 , 987 , 1046 , 1063 ) , NCI-H1666 (pulmonary) ( 12 ) , NCI-H1693 (pulmonary) ( 985 ) , NCI-H1703 (squamous) ( 9 , 361 , 362 , 363 , 364 , 1024 ) , NCI-H1781 (pulmonary) ( 10 , 759 ) , NCI-H1792 (pulmonary) [LKB1 (human), no information] ( 422 , 423 ) , NCI-H1792 (pulmonary) ( 7 , 428 , 429 ) , NCI-H1838 (pulmonary) ( 836 , 939 ) , NCI-H1869 (squamous) ( 976 ) , NCI-H1944 (pulmonary) ( 1000 , 1008 ) , NCI-H1975 (pulmonary) ( 8 , 592 , 988 , 1047 ) , NCI-H1993 (pulmonary) ( 1040 ) , NCI-H2023 (pulmonary) ( 984 ) , NCI-H2030 (pulmonary) ( 18 , 943 ) , NCI-H2052 (pulmonary) ( 833 ) , NCI-H2066 (pulmonary) ( 915 ) , NCI-H2073 (pulmonary) ( 9 , 11 , 838 ) , NCI-H2085 (pulmonary) ( 914 ) , NCI-H209 (pulmonary) ( 11 ) , NCI-H2106 (pulmonary) ( 8 ) , NCI-H2135 (pulmonary) ( 913 ) , NCI-H2228 (pulmonary) ( 10 , 14 , 516 , 517 , 935 , 1018 ) , NCI-H2286 (pulmonary) ( 942 ) , NCI-H23 (pulmonary) ( 7 ) , NCI-H2342 (pulmonary) ( 9 , 835 ) , NCI-H2347 (pulmonary) ( 1038 ) , NCI-H2405 (pulmonary) ( 12 ) , NCI-H2452 (pulmonary) ( 827 ) , NCI-H28 (pulmonary) ( 819 ) , NCI-H292 (pulmonary) ( 186 ) , NCI-H3122 (pulmonary) ( 10 , 13 , 81 , 82 , 93 , 94 ) , NCI-H322 (pulmonary) ( 18 ) , NCI-H3255 (pulmonary) ( 228 , 478 , 479 , 592 , 658 , 659 , 780 , 991 , 1030 ) , NCI-H358 (pulmonary) [LKB1 (human), no information] ( 470 ) , NCI-H358 (pulmonary) ( 469 ) , NCI-H441 (pulmonary) ( 7 , 1058 , 1059 ) , NCI-H596 (pulmonary) ( 876 , 938 ) , NCI-H647 (pulmonary) ( 937 ) , NCI-H661 (pulmonary) ( 10 , 1001 ) , NCI-H838 (pulmonary) ( 11 , 1007 ) , NCI-H929 (B lymphocyte) ( 407 ) , NKM-1 (myeloid) ( 900 , 1003 ) , NPC (neural crest) ( 16 ) , NUGC-2 (gastric) ( 582 ) , NUGC-3 (gastric) ( 575 ) , NUGC-4 (gastric) ( 583 ) , OCUG-1 ( 509 ) , OCUM-1 (gastric) ( 571 ) , OPM-1 (B lymphocyte) ( 824 , 994 ) , ovary ( 149 , 150 , 151 , 158 , 159 , 225 , 226 , 227 , 599 , 600 , 602 , 603 ) , OVKATE (ovarian) ( 139 ) , OVMANA (ovarian) ( 120 , 140 ) , OVMIU (ovarian) ( 152 ) , OVTOKO (ovarian) ( 153 , 154 ) , OZ (bile-duct cell) [RAIG1 (human), knockdown] ( 45 , 46 ) , OZ (bile-duct cell) ( 47 , 475 ) , PA-1 (ovarian) ( 864 ) , pancreas ( 355 , 559 ) , PC9 (pulmonary) ( 5 , 826 ) , PC9-IR (pulmonary) ( 5 , 727 , 825 ) , PC9-TAR (pulmonary) ( 730 ) , PLC/PRF/5 (hepatic) ( 419 ) , RD18 (muscle cell) ( 19 ) , RERF-GC-1B (gastric) ( 572 ) , RKO (intestinal) ( 968 ) , RMG1 (ovarian) ( 142 , 155 ) , RMUG-S (ovarian) ( 141 ) , RPMI-8266 (plasma cell) ( 822 , 823 , 992 ) , SACC-83 (salivary gland) ( 483 , 485 ) , salivary gland ( 461 , 462 , 463 , 464 , 465 ) , Saos-2 (bone cell) ( 19 ) , Scaber (squamous) ( 773 ) , SCH (gastric) ( 586 ) , SEM (B lymphocyte) ( 135 , 359 , 360 , 785 , 787 , 901 , 1035 , 1049 ) , SH-SY5Y (neural crest) ( 2 , 144 , 160 , 161 ) , SK-ES-1 ( 611 ) , SK-HEP-1 (endothelial) ( 410 ) , SK-LMS-1 (muscle cell) ( 19 ) , SK-N-BE(2) (neural crest) ( 2 , 147 , 567 ) , SK-N-MC (neural crest) ( 2 ) , SKBr3 (breast cell) ( 1011 ) , skin ( 260 , 450 , 451 , 454 , 507 ) , SKNAS (neural crest) ( 2 , 934 ) , SKNDZ (neural crest) ( 2 , 807 ) , SKNFI (neural crest) ( 2 , 808 ) , SKNSH (neural crest) ( 2 , 928 ) , SMS-KCN-A (neural crest) ( 2 , 145 ) , SNB-19 (glial) ( 929 , 931 ) , SNU-1079 (hepatic) ( 456 ) , SNU-1196 (hepatic) ( 453 ) , SNU-16 (gastric) ( 844 ) , SNU-308 (bile-duct cell) ( 457 ) , SNU-398 (hepatic) ( 455 ) , SNU-449 (hepatic) ( 409 ) , SNU-478 (bile-duct cell) ( 458 ) , SNU-5 (gastric) ( 758 ) , spleen ( 569 ) , stomach ( 297 , 298 , 299 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 553 , 554 , 555 , 556 , 561 , 562 , 563 , 564 , 568 , 580 ) , SU-DHL-8 (B lymphocyte) ( 922 ) , SUP-B15 (B lymphocyte) ( 877 , 1057 ) , SW1088 (glial) ( 933 ) , SW1710 (bladder cell) ( 725 ) , SW1783 (glial) ( 940 ) , SW48 (intestinal) ( 856 ) , SW480 (intestinal) ( 997 ) , SW780 (bladder cell) ( 723 ) , T1-73 (bone cell) ( 612 ) , T98G (glial) ( 974 ) , thymus ( 113 , 114 ) , U-118MG (glial) ( 89 , 90 , 101 , 1029 ) , U266 (plasma cell) ( 408 ) , U2OS (bone cell) ( 19 ) , UACC-812 (breast cell) ( 719 ) , UM-UC-1 (bladder cell) ( 813 ) , VACO432 (ovarian) ( 967 ) , XG7 (B lymphocyte) ( 912 ) , ZR-75-30 (breast cell) ( 751 , 752 )

Upstream Regulation
Regulatory protein:
CSFR (human) ( 143 )
Kinases, in vitro:
EGFR (human) ( 1073 )
Treatments:
ephrin_B1 ( 233 ) , ephrin_B2 ( 233 ) , FGF2 ( 134 ) , gefitinib ( 228 ) , HGF ( 78 ) , imatinib ( 877 ) , ischemia ( 6 ) , Su11274 ( 228 )

References 

1

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

2

Palacios-Moreno J, et al. (2015) Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts. PLoS Comput Biol 11, e1004130
25884760   Curated Info

3

Johnson H, White FM (2014) Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma. J Proteome Res 13, 4581-93
24927040   Curated Info

4

Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94
25159151   Curated Info

5

Yoshida T, et al. (2014) Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer. Clin Cancer Res 20, 4059-74
24919575   Curated Info

6

Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704
24719451   Curated Info

7

Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

8

Rikova K, Hall B (2013) CST Curation Set: 20738, 21165, 30164, 30165, 30166; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

9

Rikova K, Hall B (2013) CST Curation Set: 20739, 21166, 30167, 30168, 30169; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

10

Rikova K, Hall B (2013) CST Curation Set: 20740, 21167, 30170, 30171, 30172; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

11

Rikova K, Hall B (2013) CST Curation Set: 20742, 21169, 30176, 30177, 30178; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

12

Rikova K, Hall B (2013) CST Curation Set: 20741, 21168, 30173, 30174, 30175; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

13

Rikova K (2013) CST Curation Set: 18450; Year: 2013; Biosample/Treatment: cell line, H3122/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

14

Rikova K (2013) CST Curation Set: 18449; Year: 2012; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

15

Johnson H, Lescarbeau RS, Gutierrez JA, White FM (2013) Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion. J Proteome Res 12, 1856-67
23438512   Curated Info

16

DeNardo BD, et al. (2013) Quantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma. PLoS One 8, e82513
24349301   Curated Info

17

Johnson H, et al. (2012) Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Mol Cell Proteomics 11, 1724-40
22964225   Curated Info

18

Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68
22617229   Curated Info

19

Bai Y, et al. (2012) Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res 72, 2501-11
22461510   Curated Info

20

Mulhern D (2012) CST Curation Set: 14193; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

21

Zhou J (2012) CST Curation Set: 14105; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

22

Zhou J (2012) CST Curation Set: 14107; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

23

Possemato A (2012) CST Curation Set: 14062; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

24

Possemato A (2012) CST Curation Set: 14063; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

25

Possemato A (2012) CST Curation Set: 14058; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

26

Possemato A (2012) CST Curation Set: 14059; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

27

Zhou J (2012) CST Curation Set: 14007; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

28

Zhou J (2012) CST Curation Set: 14008; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

29

Zhou J (2012) CST Curation Set: 13888; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

30

Zhou J (2012) CST Curation Set: 13889; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

31

Zhou J (2012) CST Curation Set: 13898; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

32

Zhou J (2012) CST Curation Set: 13899; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

33

Zhou J (2012) CST Curation Set: 13884; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

34

Zhou J (2012) CST Curation Set: 13885; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

35

Zhou J (2012) CST Curation Set: 13886; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

36

Zhou J (2012) CST Curation Set: 13887; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

37

Mulhern D (2012) CST Curation Set: 13932; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

38

Zhou J (2012) CST Curation Set: 13838; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

39

Zhou J (2012) CST Curation Set: 13839; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

40

Zhou J (2012) CST Curation Set: 13840; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

41

Zhou J (2012) CST Curation Set: 13841; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

42

Zhou J (2012) CST Curation Set: 13688; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

43

Zhou J (2012) CST Curation Set: 13689; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

44

Tucker M (2012) CST Curation Set: 13495; Year: 2012; Biosample/Treatment: cell line, Colo-680N[RAIG1(knockdown)]/GPRC5A knockdown; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

45

Tucker M (2012) CST Curation Set: 13501; Year: 2012; Biosample/Treatment: cell line, OZ[RAIG1(knockdown)]/GPRC5A knockdown; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

46

Tucker M (2012) CST Curation Set: 13502; Year: 2012; Biosample/Treatment: cell line, OZ[RAIG1(knockdown)]/GPRC5A knockdown; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

47

Tucker M (2012) CST Curation Set: 13503; Year: 2012; Biosample/Treatment: cell line, OZ/untreated; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

48

Mulhern D (2012) CST Curation Set: 13331; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

49

Mulhern D (2012) CST Curation Set: 13332; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

50

Mulhern D (2012) CST Curation Set: 13333; Year: 2012; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

51

Zhou J (2011) CST Curation Set: 12806; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

52

Zhou J (2011) CST Curation Set: 12808; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

53

Zhou J (2011) CST Curation Set: 12810; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

54

Zhou J (2011) CST Curation Set: 12811; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

55

Mulhern D (2011) CST Curation Set: 13266; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

56

Mulhern D (2011) CST Curation Set: 13267; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

57

Mulhern D (2011) CST Curation Set: 13268; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

58

Mulhern D (2011) CST Curation Set: 12645; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

59

Mulhern D (2011) CST Curation Set: 12853; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

60

Mulhern D (2011) CST Curation Set: 12854; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

61

Mulhern D (2011) CST Curation Set: 12855; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

62

Moritz A (2011) CST Curation Set: 12514; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

63

Moritz A (2011) CST Curation Set: 12515; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

64

Moritz A (2011) CST Curation Set: 12516; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

65

Moritz A (2011) CST Curation Set: 12517; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

66

Moritz A (2011) CST Curation Set: 12518; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

67

Moritz A (2011) CST Curation Set: 12519; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

68

Moritz A (2011) CST Curation Set: 12381; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P , PTMScan(R) PLK Binding Motif (SpTP) Immunoaffinity Beads Cat#: 1995
Curated Info

69

Moritz A (2011) CST Curation Set: 12382; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P , PTMScan(R) PLK Binding Motif (SpTP) Immunoaffinity Beads Cat#: 1995
Curated Info

70

Moritz A (2011) CST Curation Set: 12383; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P , PTMScan(R) PLK Binding Motif (SpTP) Immunoaffinity Beads Cat#: 1995
Curated Info

71

Moritz A (2011) CST Curation Set: 12369; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

72

Moritz A (2011) CST Curation Set: 12370; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

73

Moritz A (2011) CST Curation Set: 12371; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

74

Moritz A (2011) CST Curation Set: 12372; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

75

Moritz A (2011) CST Curation Set: 12373; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

76

Moritz A (2011) CST Curation Set: 12374; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

77

Bergström Lind S, et al. (2011) Toward a comprehensive characterization of the phosphotyrosine proteome. Cell Signal 23, 1387-95
21447384   Curated Info

78

Organ SL, et al. (2011) Quantitative Phospho-Proteomic Profiling of Hepatocyte Growth Factor (HGF)-MET Signaling in Colorectal Cancer. J Proteome Res 10, 3200-11
21609022   Curated Info

79

Possemato A (2011) CST Curation Set: 11905; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

80

Possemato A (2011) CST Curation Set: 11906; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

81

Possemato A (2011) CST Curation Set: 11907; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

Possemato A (2011) CST Curation Set: 11908; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

83

Possemato A (2011) CST Curation Set: 11909; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

84

Possemato A (2011) CST Curation Set: 11910; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

85

Possemato A (2011) CST Curation Set: 11911; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

Possemato A (2011) CST Curation Set: 11912; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

87

Possemato A (2011) CST Curation Set: 11913; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

88

Possemato A (2011) CST Curation Set: 11914; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

89

Possemato A (2011) CST Curation Set: 11915; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

90

Possemato A (2011) CST Curation Set: 11916; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

91

Possemato A (2011) CST Curation Set: 11917; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

92

Possemato A (2011) CST Curation Set: 11918; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

93

Possemato A (2011) CST Curation Set: 11919; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

94

Possemato A (2011) CST Curation Set: 11920; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

95

Possemato A (2011) CST Curation Set: 11921; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

96

Possemato A (2011) CST Curation Set: 11922; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

97

Possemato A (2011) CST Curation Set: 11923; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

98

Possemato A (2011) CST Curation Set: 11924; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

99

Possemato A (2011) CST Curation Set: 11925; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

100

Possemato A (2011) CST Curation Set: 11926; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

101

Possemato A (2011) CST Curation Set: 11927; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

102

Artemenko KA, et al. (2011) Optimization of immunoaffinity enrichment and detection: toward a comprehensive characterization of the phosphotyrosine proteome of K562 cells by liquid chromatography-mass spectrometry. Analyst 136, 1971-8
21403953   Curated Info

103

Ren H (2011) CST Curation Set: 11777; Year: 2011; Biosample/Treatment: cell line, RP94/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

104

Ren H (2011) CST Curation Set: 11781; Year: 2011; Biosample/Treatment: cell line, RP98/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

105

Ren H (2011) CST Curation Set: 11784; Year: 2011; Biosample/Treatment: cell line, RP101/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

106

Ren H (2011) CST Curation Set: 11785; Year: 2011; Biosample/Treatment: cell line, RP102/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

107

Ren H (2011) CST Curation Set: 11786; Year: 2011; Biosample/Treatment: cell line, RP103/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

108

Ren H (2011) CST Curation Set: 11787; Year: 2011; Biosample/Treatment: cell line, RP104/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

109

Ren H (2011) CST Curation Set: 11788; Year: 2011; Biosample/Treatment: cell line, RP105/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

110

Ren H (2011) CST Curation Set: 11790; Year: 2011; Biosample/Treatment: cell line, FAC 13N/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

111

Ren H (2011) CST Curation Set: 11791; Year: 2011; Biosample/Treatment: cell line, FAC 13T/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

112

Pighi C, et al. (2011) Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. Cell Oncol (Dordr) 34, 141-53
21394647   Curated Info

113

Li Y (2011) CST Curation Set: 10458; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

Li Y (2011) CST Curation Set: 10460; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

115

Li Y (2011) CST Curation Set: 10520; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

116

Tucker M (2011) CST Curation Set: 10949; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

117

Tucker M (2011) CST Curation Set: 10951; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

118

Tucker M (2011) CST Curation Set: 10952; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

119

Tucker M (2011) CST Curation Set: 10954; Year: 2011; Biosample/Treatment: cell line, Jurkat/pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

120

Ren H (2011) CST Curation Set: 11303; Year: 2011; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

121

Li Y (2011) CST Curation Set: 10453; Year: 2011; Biosample/Treatment: heart, cardiac/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

122

Li Y (2011) CST Curation Set: 10501; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

123

Li Y (2011) CST Curation Set: 10439; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

124

Moritz A (2011) CST Curation Set: 11304; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

Moritz A (2011) CST Curation Set: 11305; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

126

Moritz A (2011) CST Curation Set: 11306; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

127

Moritz A (2011) CST Curation Set: 11307; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

128

Moritz A (2011) CST Curation Set: 11308; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

129

Moritz A (2011) CST Curation Set: 11309; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

130

Moritz A (2011) CST Curation Set: 11310; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

131

Moritz A (2011) CST Curation Set: 11311; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

132

Moritz A (2011) CST Curation Set: 11312; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

133

Gu TL, et al. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 6, e15640
21253578   Curated Info

134

Ding VM, et al. (2011) Tyrosine phosphorylation profiling in fgf-2 stimulated human embryonic stem cells. PLoS One 6, e17538
21437283   Curated Info

135

Gu TL, et al. (2011) Survey of activated FLT3 signaling in leukemia. PLoS One 6, e19169
21552520   Curated Info

136

Tucker M (2010) CST Curation Set: 10852; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

137

Tucker M (2010) CST Curation Set: 10853; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991